TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 21,210,834 | 18,707,753 | 17,799,017 |
Financial expenses | 24,994 | 158,115 | 7,512 |
Earnings before taxes | 3,804,263 | 3,518,688 | 2,925,912 |
EBITDA | 4,842,299 | 4,724,544 | 3,869,731 |
Total assets | 31,479,494 | 28,873,657 | 25,384,615 |
Current assets | 22,514,652 | 20,234,043 | 17,889,080 |
Current liabilities | 2,967,038 | 2,913,285 | 2,301,336 |
Equity capital | 26,912,705 | 24,533,041 | 21,654,462 |
- share capital | 892 | 894 | 743 |
Employees (average) | 9,734 | 8,336 | 8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 85.5% | 85.0% | 85.3% |
Turnover per employee | 2,179 | 2,244 | 2,186 |
Profit as a percentage of turnover | 17.9% | 18.8% | 16.4% |
Return on assets (ROA) | 12.2% | 12.7% | 11.6% |
Current ratio | 758.8% | 694.5% | 777.3% |
Return on equity (ROE) | 14.1% | 14.3% | 13.5% |
Change turnover | 4,018,421 | 1,245,650 | 655,857 |
Change turnover % | 23% | 7% | 4% |
Chg. No. of employees | 1,398 | 195 | 233 |
Chg. No. of employees % | 17% | 2% | 3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.